Vaccinex, Inc.
SEMAPHORIN-4D ANTAGONISTS FOR USE IN CANCER THERAPY
Last updated:
Abstract:
The disclosure relates to methods for treating cancer comprising determining certain patient biomarker levels prior to treatment.
Status:
Application
Type:
Utility
Filling date:
27 Mar 2020
Issue date:
8 Oct 2020